Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
PPAR Res. 2012;2012:738785. doi: 10.1155/2012/738785. Epub 2012 Nov 11.
Hepatic ischemia-reperfusion (IR) injury is a serious clinical problem. Minimizing the adverse effect of ischemia-reperfusion injury after liver surgery or trauma is an urgent need. It has been proved that besides the effect of regulating the lipid and lipoprotein metabolism, PPARα also undertakes the task of organ protection. In this paper, related literature has been summarized and we come to the conclusion that administration of PPARα agonists can strengthen the antioxidant and anti-inflammation defense system by the upregulation of the expression of antioxidant enzymes and inhibition of NF-κB activity. This may provide a potential clinical treatment for hepatic ischemia-reperfusion injury.
肝缺血再灌注(IR)损伤是一个严重的临床问题。减少肝手术后或创伤后缺血再灌注损伤的不良影响是当务之急。已经证明,除了调节脂质和脂蛋白代谢的作用外,PPARα 还承担着器官保护的任务。本文总结了相关文献,得出结论,给予 PPARα 激动剂可以通过上调抗氧化酶的表达和抑制 NF-κB 活性来增强抗氧化和抗炎防御系统。这可能为肝缺血再灌注损伤提供一种潜在的临床治疗方法。